Inactive Instrument

Insiders InDex Pharmaceuticals Holding AB (publ) Nasdaq Stockholm

Equities

SE0008966295

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

InDex Pharmaceuticals Holding AB Approves the Election of Karl Tobieson as Board Member	05-07	CI
Index Pharmaceuticals Holding AB Announces Board Resignations	04-05	CI
InDex Pharmaceuticals CEO, CFO to Step Down as Operations Cease	03-26	MT
Index Pharmaceuticals Holding AB Announces Resignation of Johan Giléus as Deputy CEO	03-26	CI
InDex Pharmaceuticals Holding AB Announces Resignation of Jenny Sundqvist as CEO, Effective September 26, 2024	03-26	CI
InDex Pharmaceuticals Holding AB Announces Composition of the Nomination Committee	23-10-30	CI
InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2023 Annual General Meeting	22-10-26	AQ
InDex Pharmaceuticals Holding AB Announces Appointment of Nomination Committee for the 2023 Annual General Meeting	22-10-26	CI
InDex Pharmaceuticals Holding AB Appoints Jenny Sundqvist as New CEO, Effective January 1, 2023	22-10-10	CI
InDex Pharmaceuticals Holding AB Announces Board Appointments	22-06-01	CI
InDex Pharmaceuticals Names New Chief Development Officer, Chief Medical Officer	22-05-02	MT
InDex Pharmaceuticals Strengthens the Organization with Eva Arlander as Chief Development Officer and Announces Changes in the Composition of the Management Team	22-05-02	CI
InDex Pharmaceuticals CEO Resigns	22-04-11	MT
InDex Pharmaceuticals Holding AB Announces CEO Changes	22-04-11	CI
InDex Pharmaceuticals COO To Step Down To Pursue WntResearch CEO Post	22-02-13	MT
InDex Pharmaceuticals Holding AB Announces Resignation of Pernilla Sandwall as Chief Operating Officer	22-02-13	CI
InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2022 Annual General Meeting	21-11-10	AQ
Index Pharmaceuticals Holding AB Announces Composition of Nomination Committee	21-11-10	CI
Index Pharmaceuticals : Names Heads For Phase III Cobitolimod Trials	21-08-23	MT
InDex Pharmaceuticals Holding AB Announces Appointment of Anders Bröijersén Is Joining Index as Senior Medical Director Clinical Operations and Johan Levin as Project Manager Clinical Operations	21-08-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders InDex Pharmaceuticals Holding AB (publ) Nasdaq Stockholm

Equities

SE0008966295

Insiders

Filters